1 / 5

Rare Neurological Disease Treatment Market to 2027

The rare neurological disease treatment market is expected to reach US$13,830.96 Mn in 2027 from US$ 7,300.12Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2020-2027.<br>Neurological diseases having less diagnostics and treatment options affecting small number of population is termed as rare neurological diseases. These diseases target the nervous system, which include the brain, spinal cord, and all the nerves that run throughout the human body. Amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, Huntington's disease are few examples of rare neurological

Swapnaja
Télécharger la présentation

Rare Neurological Disease Treatment Market to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rare Neurological Disease Treatment Market  Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Other Indication); Drug Type (Organic Compounds, Biologics); Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies); Mode of Administration (Oral, Injectables) and Geography

  2. Rare Neurological Disease Treatment Market  Current and future MarketScenario • According to our new market research study on “Rare Neurological Disease Treatment Market to 2027 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market is expected to reach US$ 3,653.92 million by 2027 from US$ 2,541.07 million in 2019.

  3. Rare Neurological Disease Treatment Market  MarketSegments by Indication Narcolepsy Amyotrophic Lateral Sclerosis Alzheimer's Disease Multiple Sclerosis Spinal Muscular Atrophy (SMA, Duchenne Muscular Dystrophy Other Indication Drug Type Organic Compounds Biologics Distribution Channel Online Pharmacies Hospital Pharmacies Retail Pharmacies

  4. Rare Neurological Disease Treatment Market   LeadingPlayers Company Profiles in Rare Neurological Disease Treatment Market are: Allergan plc Bayer AG GlaxoSmithKline plc Johnson & Johnson Services Inc Merck & Co. Inc. Novartis AG Pfizer Inc. Sanofi Teva Pharmaceutical Industries Ltd Takeda Pharmaceutical

  5. Rare Neurological Disease Treatment Market Access Full Research Report at: https://www.theinsightpartners.com/reports/rare-neurological-disease-treatment-market Thank You! Thank You!

More Related